WARSAW, Ind.--()--Biomet, Inc., a global leader in the manufacture of orthopaedic and biotechnology products, announces the European launch of a new stemless shoulder product, the Comprehensive Nano shoulder, featured at the 2012 SECEC (Société Européenne pour la Chirurgie de l'Epaule et du Coude/European Society for Surgery of the Shoulder and the Elbow) Annual Congress, September 19-22 in Dubrovnik, Croatia.
“Humeral replacement with a stemless implant preserves bone stock, simplifies the surgical technique, and allows an easy implantation”
The Comprehensive Nano shoulder was developed based on the clinical heritage of the Biomet T.E.S.S. stemless shoulder*, which has been clinically successful since its launch in Europe in 2004.1-5 The bone conserving shoulder design allows the surgeon to fit the implant to each individual patient by reproducing native humeral head version and inclination. The Comprehensive Nano shoulder is compatible with all configurations of the Comprehensive shoulder system, and is the first stemless device to provide surgeons with intra-operative flexibility to easily convert from a Comprehensive Nano hemi-arthroplasty to a reverse or total shoulder arthroplasty using the same core instruments and without removal of the well-fixed humeral component.
Renaat Vermeulen, President of Biomet EMEA, stated, “The Comprehensive Nano shoulder allows Biomet to build on the strong position we have established in stemless shoulder arthroplasty with the T.E.S.S. shoulder, the pioneering design in Europe. The Comprehensive Nano shoulder will provide surgeons and patients with a truly second generation stemless shoulder with an unmatched clinical heritage and intra-operative flexibility to help surgeons deliver the optimal treatment to each patient.”
“Humeral replacement with a stemless implant preserves bone stock, simplifies the surgical technique, and allows an easy implantation,” said J. Teissier, Clinique Saint Jean, Montpellier, France.
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses large joint reconstructive products, including orthopedic joint replacement devices, and bone cements and accessories; sports medicine, extremities and trauma products, including internal and external orthopedic fixation devices; spine and bone healing products, including spine hardware, spinal stimulation devices, and orthobiologics, as well as electrical bone growth stimulators and softgoods and bracing; dental reconstructive products; and other products, including microfixation products and autologous therapies. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.
*Not available for commercial distribution in the United States.
1 Huguet D, DeClercq G, Rio B, Teissier J, Zipoli B, TESS Group. Results of a New Stemless Shoulder Prosthesis: Radiologic Proof of Maintained Fixation and Stability after a Minimum of Three Years’ Follow-Up. J Shoulder Elbow Surg 2010; 19: 847-852.
2 Kadum B, Mafi N, Norberg S, Sayed-Noor AS. Results of the Total Evolutive Shoulder System (TESS): A Single-Centre Study of 56 Consecutive Patients. Arch Orthop Trauma Surg 2011; 131: 1623-9.
3 Geurts GF, van Riet RP, Jansen N, Declercq G. Placement of the Stemless Humeral Component in the Total Evolutive Shoulder System (TESS). Tech Hand Up Extrem Surg 2010; 14: 214-7.
4 Razmjou H, Holtby R, Christakis M, Axelrod T, Richards R. Impact of Prosthetic Design on Clinical and Radiological Outcomes of Total Shoulder Arthroplasty: A Prospective Study. J Shoulder Elbow Surg 2012; 1-9.
5 Castricini R, De Benedetto M, Pirani P, Panfoli N, Pace N. Shoulder Hemiarthroplasty for Fractures of the Proximal Humerus. Musculoskelet Surg 2011; 95: S49-S54.